6d
Setbacks in Parkinson’s Drugs Highlight Need for Novel Therapies This month has seen the failure of main assets in the ...
Analyst Jason McCarthy from Maxim Group reiterated a Buy rating on Gain Therapeutics (GANX – Research Report) and keeping the price ...
An intelligent self-adjusting brain pacemaker could improve the quality-of-life for those living with Parkinson’s disease ...
Researchers Develop Analytical Pipeline to Identify Unexploited ... In the future, the discovery may be used in treatment for Parkinson's ... Jan. 23, 2024 — Scientists argue that Parkinson's ...
Researchers Develop Analytical Pipeline to Identify Unexploited ... activity could provide continual and improved treatment for the symptoms of Parkinson's disease (PD) in certain ...
Hope remains that Roche’s prasinezumab can overcome recent string of failures in Parkinson’s disease
This month has seen the failure of main assets in the Parkinson ... 52 and 72 weeks of treatment against placebo. Similarly, Sanofi announced on 5 February that its pipeline asset, venglustat ...
6don MSN
Boosting a certain brain protein could help slow the progression of Alzheimer’s disease, a new study has found. The ...
Coya’s investigational product candidate pipeline leverages multiple therapeutic ... of action that is now being developed for the treatment of Amyotrophic Lateral Sclerosis, Frontotemporal Dementia, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback